posted on 2000-07-13, 00:00authored byHaim Tsubery, Itzhak Ofek, Sofia Cohen, Mati Fridkin
Polymyxin B nonapeptide (PMBN), a cationic cyclic peptide derived by enzymatic processing
from the naturally occurring peptide polymyxin B, is able to increase the permeability of the
outer membrane of Gram-negative bacteria toward hydrophobic antibiotics probably by binding
to the bacterial lipopolysaccharide (LPS). We have synthesized 11 cyclic analogues of PMBN
and evaluated their activities compared to that of PMBN. The synthetic peptides were much
less potent than PMBN in their capacity to sensitize Escherichia coli and Klebsiella pneumoniae
toward novobiocin and to displace dansyl-PMBN from Escherichia coli LPS. Moreover, unlike
PMBN, none of the analogues were able to inhibit the growth of Pseudomonas aeruginosa.
The structural−functional features of PMBN were characterized and identified with regard to
the ring size, the distance between positive charges and peptide backbone, the chirality of the
dPhe-Leu domain, and the nature of the charged groups. Apparently, the structure of PMBN
is highly specific for efficient perturbation of the outer membrane of Gram-negative bacteria
as well as for LPS binding. The present study further increases our understanding of the
complex PMBN−LPS and may, potentially, enable the design of compounds having enhanced
permeabilization potency of the Gram-negative outer membrane.